CISAPRIDE ( DrugBank: Cisapride )


1 disease
IDDisease name (Link within this page)Number of trials
13Multiple sclerosis/Neuromyelitis optica1

13. Multiple sclerosis/Neuromyelitis optica


Clinical trials : 3,342 Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-023996-25-BE
(EUCTR)
21/12/201025/11/2010The effect of fluoxetine and 5-HT4 serotonin receptor agonists on cerebral axonal energy metabolism and glutamate levels in multiple sclerosis.The effect of fluoxetine and 5-HT4 serotonin receptor agonists on cerebral axonal energy metabolism and glutamate levels in multiple sclerosis. Multiple sclerosis (both relapsing remitting and progressive forms)Product Name: fluoxetine
Other descriptive name: FLUOXETINE
Product Name: Cisapride
INN or Proposed INN: CISAPRIDE
Product Name: Prucalopride
INN or Proposed INN: PRUCALOPRIDE
NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
32Belgium